BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26555339)

  • 21. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
    Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A
    Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.
    Suh SH; Choi HS; Kim CS; Kim IJ; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
    Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
    Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndrome.
    Zheng K; Perry J; Harvey SJ; Sado Y; Ninomiya Y; Jefferson B; Jacobs R; Hudson BG; Thorner PS
    Kidney Int; 2005 Nov; 68(5):2121-30. PubMed ID: 16221211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexisting presentation of two rare genetic variants of autosomal dominant polycystic kidney disease and Alport syndrome.
    Venda J; Henriques A; Leal R; Alves R
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38740443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
    Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
    Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome.
    Firat EAM; Buhl EM; Bouteldja N; Smeets B; Eriksson U; Boor P; Klinkhammer BM
    Am J Pathol; 2024 May; 194(5):641-655. PubMed ID: 38309427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
    Maziers N; Dahan K; Pirson Y
    Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
    Abrahamson DR; Prettyman AC; Robert B; St John PL
    Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel COL4A3 gene mutations in a consanguineous family with autosomal recessive Alport syndrome.
    Sirisena ND; Thalgahagoda S; Abeyagunawardena A; Neumann M; Schmudlach HO; Jayasekara RW; Dissanayake VH
    Nephrology (Carlton); 2015 Aug; 20(8):580. PubMed ID: 26194984
    [No Abstract]   [Full Text] [Related]  

  • 34. Ocular features in Alport syndrome: pathogenesis and clinical significance.
    Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
    Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.
    Ding W; Yousefi K; Goncalves S; Goldstein BJ; Sabater AL; Kloosterboer A; Ritter P; Lambert G; Mendez AJ; Shehadeh LA
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
    Rubel D; Boulanger J; Craciun F; Xu EY; Zhang Y; Phillips L; Callahan M; Weber W; Song W; Ngai N; Bukanov NO; Shi X; Hariri A; Husson H; Ibraghimov-Beskrovnaya O; Liu S; Gross O
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203245
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
    Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
    ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell therapies benefit Alport syndrome.
    LeBleu V; Sugimoto H; Mundel TM; Gerami-Naini B; Finan E; Miller CA; Gattone VH; Lu L; Shield CF; Folkman J; Kalluri R
    J Am Soc Nephrol; 2009 Nov; 20(11):2359-70. PubMed ID: 19833902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.